+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID06382051

Evaluating a Modified Psoriasis Epidemiology Screening Tool to Improve Psoriatic Arthritis Detection in Adults with Moderate-to-Severe Plaque Psoriasis in Canada

Led by Novartis Pharmaceuticals · Updated on 2026-09-28

502

Participants Needed

30

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate how adding two new questions and pictures to the Psoriasis Epidemiology Screening Tool PEST affects the potential diagnosis of psoriatic arthritis PsA in adults with moderate-to-severe plaque psoriasis PsO in Canada. The study focuses on patients who may need biologic Disease-Modifying Antirheumatic Drugs bDMARDs treatment and seeks to improve early detection of PsA. The study is prospective and involves multiple centers. Participants will first complete a modified PEST screening questionnaire, called PESTpictures2, at their initial dermatologist visit. This version includes the original 5 questions, two additional questions about morning stiffness and nighttime pain, and pictures to help patients identify symptoms like swollen joints and fingernail changes. Those who screen positive will have a follow-up visit with a rheumatologist for a thorough PsA diagnosis. At the end of the study, a remote visit with the dermatologist will record the participants bDMARD treatment choice and status. Patients will be enrolled for up to 120 days. During the study, participants will complete questionnaires and undergo assessments by dermatologists and rheumatologists. Researchers will measure the accuracy of the modified screening tool in predicting PsA, patient experience with the questionnaire, and characteristics of those with positive or negative screening results. Safety and treatment decisions related to bDMARDs will also be monitored. The main outcome is the positive predictive value of the screening tool within about one year.

CONDITIONS

Brief Title

Modifying PEST for Psoriatic Arthritis Screening

Research Team

N

Novartis Pharmaceuticals

N

Novartis Pharmaceuticals

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here